| Institution: | 1. Amyloidosis Research Consortium, 320 Nevada Street, Suite 210, Newton, MA 02460, USA;2. Mackenzie’s Mission, Great Falls, Virginia;1. Divsion of Hematology-Oncology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA;2. Department of Molecular Medicine, Amyloidosis Research and Treatment Center Foundations, “Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo”, University of Pavia, Viale Golgi, 19 IT, Pavia 27100, Italy;1. Amyloidosis Center and Section of Hematology and Medical Oncology, Department of Medicine, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA;2. Amyloidosis and Cancer Theranostics Program, Preclinical and Diagnostic Molecular Imaging Laboratory, The University of Tennessee Graduate School of Medicine, 1924 Alcoa Highway, Knoxville, TN 37920, USA;1. Division of Hematology, Mayo Clinic, 200 Southwest First Street, W10, Rochester, MN 55905, USA;2. Department of Internal Medicine V, Division of Hematology/Oncology, Amyloidosis Center, Heidelberg University Hospital, Im Neuenheimer Feld 450, Heidelberg 69120, Germany;1. National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London NW3 2PF, UK;2. Multiple Myeloma and Amyloidosis Service, Herbert Irving Pavillion, R 953, 161 Fort Washington Avenue, New York, NY 10032, USA;1. Department of Medicine, Division of Hematology, University of Miami/Sylvester Comprehensive Cancer Center, 1475 Northwest 12th Avenue, Miami, FL 33136, USA;2. Boston University School of Medicine and Boston Medical Center, 72 East Concord Street, K-503, Boston, MA 02118, USA |
